Connecta Therapeutics, a clinical stage biotechnology company focusing on the development of new treatments for central nervous system (CNS) disorders without therapeutic options, has been granted ...
Read moreUn grupo de investigación muestra que la plasticidad neuronal y las alucinaciones de drogas como el LSD están causados por receptores neuronales diferentes y, por tanto, se pueden separar
Read moreNuevas oportunidades para la medicina de precisión plantean la atención de los pacientes desde una perspectiva personalizada, considerando sus características clínicas, genéticas y de estilo de v...
Read moreEl Hospital 12 de Octubre participa en un ensayo clínico internacional que demuestra que un inhibidor denominado vorasidenib, que se administra vía oral, detiene varios años la progresión de un ti...
Read moreThey have led the largest brain imaging study of children aged 9 to 11 years relating duration of breastfeeding to increased cortical gray matter volume at this age.
Read moreVHIO led and participated in a dozen studies on lung cancer that were presented at the American Society of Clinical Oncology (ASCO) meeting held June 2-6 in Chicago.
Read moreEl proyecto SAUVOLIBE, coordinado por la Universidad de Córdoba y en el que participan las empresas COVAP y DOSCADESA, investiga cómo el proceso de fermentación y los hidratos de carbono influyen e...
Read moreUn estudio publicado en la revista Journal of Neuroscience ha identificado nuevas alteraciones en otros circuitos neuronales en modelos de ratones con los que se estudia esta patología que altera de ...
Read moreCertain patterns of gut bacteria are linked to better physical but also mental health. These bacteria may have an anti-inflammatory role and produce millions of neuroactive compounds with the ability ...
Read moreEl 5% of children under the age of 7 in Spain have asthma, and 14% have allergies, mainly allergic rhinitis. Considering that in Spain there are about 6 million people under the age of 14, the data in...
Read moreIt is the first treatment in the last 30 years that represents a relative improvement of 38% in the overall survival of patients compared to standard treatment. The results of Phase III study ZUMA-7 ...
Read moreThese results offer new hope for patients in the early stages of the disease, as they represent the largest reduction in mortality ever recorded in the field of lung cancer and highlight how targeted ...
Read more